Growth Differentiation Factor-15 and Risk of CKD Progression
- PMID: 28159780
- PMCID: PMC5491285
- DOI: 10.1681/ASN.2016080919
Growth Differentiation Factor-15 and Risk of CKD Progression
Abstract
Growth differentiation factor-15 (GDF-15) is a member of the TGF-β cytokine superfamily that is widely expressed and may be induced in response to tissue injury. Elevations in GDF-15 may identify a novel pathway involved in loss of kidney function among patients with CKD. Among participants in the Clinical Phenotyping and Resource Biobank (C-PROBE) study and the Seattle Kidney Study (SKS), we tested whether kidney tissue expression of GDF15 mRNA correlates with circulating levels of GDF-15 and whether elevations in circulating GDF-15 are associated with decline in kidney function. In matching samples of 24 patients with CKD from the C-PROBE study, circulating GDF-15 levels significantly correlated with intrarenal GDF15 transcript levels (r=0.54, P=0.01). Among the 224 C-PROBE and 297 SKS participants, 72 (32.1%) and 94 (32.0%) patients, respectively, reached a composite end point of 30% decline in eGFR or progression to ESRD over a median of 1.8 and 2.0 years of follow up, respectively. In multivariable models, after adjusting for potential confounders, every doubling of GDF-15 level associated with a 72% higher (95% confidence interval, 1.21 to 4.45; P=0.003) and 65% higher (95% confidence interval, 1.08 to 2.50; P=0.02) risk of progression of kidney disease in C-PROBE and SKS participants, respectively. These results show that circulating GDF-15 levels strongly correlated with intrarenal expression of GDF15 and significantly associated with increased risk of CKD progression in two independent cohorts. Circulating GDF-15 may be a marker for intrarenal GDF15-related signaling pathways associated with CKD and CKD progression.
Keywords: chronic kidney disease; end-stage renal disease; gene expression; glomerular filtration rate; kidney biopsy.
Copyright © 2017 by the American Society of Nephrology.
Figures
Similar articles
-
GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.Am J Kidney Dis. 2018 Oct;72(4):519-528. doi: 10.1053/j.ajkd.2018.03.025. Epub 2018 Jun 14. Am J Kidney Dis. 2018. PMID: 29866459 Free PMC article.
-
Growth differentiation factor-15 and incident chronic kidney disease: a population-based cohort study.BMC Nephrol. 2021 Oct 27;22(1):351. doi: 10.1186/s12882-021-02558-w. BMC Nephrol. 2021. PMID: 34706669 Free PMC article.
-
Association between Plasma Levels of Growth Differentiation Factor-15 and Renal Function in the Elderly: Korean Frailty and Aging Cohort Study.Kidney Blood Press Res. 2019;44(3):405-414. doi: 10.1159/000498959. Epub 2019 Jun 4. Kidney Blood Press Res. 2019. PMID: 31163432
-
GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective.J Diabetes Res. 2015;2015:490842. doi: 10.1155/2015/490842. Epub 2015 Jul 27. J Diabetes Res. 2015. PMID: 26273671 Free PMC article. Review.
-
Growth differentiation factor 15 (GDF-15) in kidney diseases.Adv Clin Chem. 2023;114:1-46. doi: 10.1016/bs.acc.2023.02.003. Epub 2023 Mar 15. Adv Clin Chem. 2023. PMID: 37268330 Review.
Cited by
-
Association between Serum GDF-15 and Cognitive Dysfunction in Hemodialysis Patients.Biomedicines. 2024 Feb 3;12(2):358. doi: 10.3390/biomedicines12020358. Biomedicines. 2024. PMID: 38397960 Free PMC article.
-
Association between plasma growth differentiation factor 15 levels and pre-eclampsia in China.Chronic Dis Transl Med. 2024 May 12;10(2):140-145. doi: 10.1002/cdt3.126. eCollection 2024 Jun. Chronic Dis Transl Med. 2024. PMID: 38872765 Free PMC article.
-
Elevated circulating growth differentiation factor 15 is related to decreased heart rate variability in chronic kidney disease patients.Ren Fail. 2021 Dec;43(1):340-346. doi: 10.1080/0886022X.2021.1880938. Ren Fail. 2021. PMID: 33567936 Free PMC article.
-
Serum Growth Differentiation Factor-15/Albumin Ratio as a 2-Year Survival Marker of End-Stage Renal Disease Patients Initiating Maintenance Hemodialysis.Diagnostics (Basel). 2022 Jan 20;12(2):257. doi: 10.3390/diagnostics12020257. Diagnostics (Basel). 2022. PMID: 35204349 Free PMC article.
-
Anemia with elevation of growth differentiation factor-15 level in linezolid treated multidrug-resistant tuberculosis: Case series of three patients.IDCases. 2022 Jul 29;29:e01591. doi: 10.1016/j.idcr.2022.e01591. eCollection 2022. IDCases. 2022. PMID: 35957807 Free PMC article.
References
-
- Kempf T, Eden M, Strelau J, Naguib M, Willenbockel C, Tongers J, Heineke J, Kotlarz D, Xu J, Molkentin JD, Niessen HW, Drexler H, Wollert KC: The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ Res 98: 351–360, 2006 - PubMed
-
- Anand IS, Kempf T, Rector TS, Tapken H, Allhoff T, Jantzen F, Kuskowski M, Cohn JN, Drexler H, Wollert KC: Serial measurement of growth-differentiation factor-15 in heart failure: Relation to disease severity and prognosis in the Valsartan Heart Failure Trial. Circulation 122: 1387–1395, 2010 - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
